报价延迟最少15分钟:2025/08/27 13:38 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
268.345 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
3.78/4.99
|
|
企业价值
10.58B
|
| 资产负债 |
|
每股账面净值
33.18
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
1.19B
|
|
每股收益
25.51
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/27 13:38 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products. |
